Asian Journal of Transfusion Science

BRIEF COMMUNICATION
Year
: 2013  |  Volume : 7  |  Issue : 1  |  Page : 73--74

Hemovigilance Program-India


Akanksha Bisht1, Surinder Singh2, Neelam Marwaha3 
1 Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, India
2 National Institute of Biologicals, Noida, Ministry of Health and Family Welfare, Government of India, India
3 Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Akanksha Bisht
129, Agroha Kunj Sec 13, Rohini, Delhi
India

A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform.


How to cite this article:
Bisht A, Singh S, Marwaha N. Hemovigilance Program-India.Asian J Transfus Sci 2013;7:73-74


How to cite this URL:
Bisht A, Singh S, Marwaha N. Hemovigilance Program-India. Asian J Transfus Sci [serial online] 2013 [cited 2021 Dec 1 ];7:73-74
Available from: https://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=73;epage=74;aulast=Bisht;type=0